The Right Heart-Pulmonary Circulation Unit and Left Heart Valve Disease.

[en] Valvular heart disease (VHD) is frequently accompanied by pulmonary hypertension (PH). In asymptomatic patients, PH is rare, although the exact prevalence is unknown and mainly stems from the severity of the VHD and the presence of diastolic dysfunction. PH can also be depicted during exercise echocardiography. PH either at rest or during exercise is also a powerful determinant of outcome and is independently associated with reduced survival, regardless of the severity of the underlying valvular pathology. Therefore, because PH is a marker of poor prognosis, assessment of PH in VHD is crucial for risk stratification and management of patients with VHD.

Disciplines :

Cardiovascular & respiratory systems

Author, co-author :

Filippetti, Laura

Voilliot, Damien

Bellino, Michele

Citro, Rodolfo

Go, Yun Yun

Lancellotti, Patrizio ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation

Language :

English

Title :

The Right Heart-Pulmonary Circulation Unit and Left Heart Valve Disease.

Publication date :

2018

Journal title :

Heart Failure Clinics

ISSN :

1551-7136

Publisher :

Saunders, United States

Volume :

Issue :

Pages :

431-442

Peer reviewed :

Peer reviewed

Commentary :

Available on ORBi :

since 21 December 2018

Statistics

Number of views

209 (3 by ULiège)

Number of downloads

369 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Fang, J.C., DeMarco, T., Givertz, M.M., et al. World Health Organization pulmonary hypertension group 2: pulmonary hypertension due to left heart disease in the adult. A summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 31:9 (2012), 913–933.
Magne, J., Pibarot, P., Sengupta, P.P., et al. Pulmonary hypertension in valvular disease: a comprehensive review on pathophysiology to therapy from the HAVEC Group. JACC Cardiovasc Imaging 8:1 (2015), 83–99.
Cooper, C.J., Jevnikar, F.W., Walsh, T., et al. The influence of basal nitric oxide activity on pulmonary vascular resistance in patients with congestive heart failure. Am J Cardiol 82:5 (1998), 609–614.
Rudski, L.G., Lai, W.W., Afilalo, J., et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23:7 (2010), 685–713 [quiz: 786–8].
le Tourneau, T., Right ventricle impairment: are we changing the paradigm in organic mitral regurgitation?. Arch Cardiovasc Dis 106:8–9 (2013), 419–422.
Badano, L.P., Ginghina, C., Easaw, J., et al. Right ventricle in pulmonary arterial hypertension: haemodynamics, structural changes, imaging, and proposal of a study protocol aimed to assess remodelling and treatment effects. Eur J Echocardiogr 11:1 (2010), 27–37.
Nagel, E., Stuber, M., Hess, O.M., Importance of the right ventricle in valvular heart disease. Eur Heart J 17:6 (1996), 829–836.
Kammerlander, A.A., Marzluf, B.A., Graf, A., et al. Right ventricular dysfunction, but not tricuspid regurgitation, is associated with outcome late after left heart valve procedure. J Am Coll Cardiol 64:24 (2014), 2633–2642.
Lancellotti, P., Magne, J., Donal, E., et al. Determinants and prognostic significance of exercise pulmonary hypertension in asymptomatic severe aortic stenosis. Circulation 126:7 (2012), 851–859.
Faggiano, P., Antonini-Canterin, F., Ribichini, F., et al. Pulmonary artery hypertension in adult patients with symptomatic valvular aortic stenosis. Am J Cardiol 85:2 (2000), 204–208.
Melby, S.J., Moon, M.R., Lindman, B.R., et al. Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis. J Thorac Cardiovasc Surg 141:6 (2011), 1424–1430.
Roselli, E.E., Abdel Azim, A., Houghtaling, P.L., et al. Pulmonary hypertension is associated with worse early and late outcomes after aortic valve replacement: implications for transcatheter aortic valve replacement. J Thorac Cardiovasc Surg 144:5 (2012), 1067–1074.e2.
Malouf, J.F., Enriquez-Sarano, M., Pellikka, P.A., et al. Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implications. J Am Coll Cardiol 40:4 (2002), 789–795.
Pai, R.G., Varadarajan, P., Kapoor, N., et al. Aortic valve replacement improves survival in severe aortic stenosis associated with severe pulmonary hypertension. Ann Thorac Surg 84:1 (2007), 80–85.
Zuern, C.S., Eick, C., Rizas, K., et al. Prognostic value of mild-to-moderate pulmonary hypertension in patients with severe aortic valve stenosis undergoing aortic valve replacement. Clin Res Cardiol 101:2 (2012), 81–88.
Barbash, I.M., Escarcega, R.O., Minha, S., et al. Prevalence and impact of pulmonary hypertension on patients with aortic stenosis who underwent transcatheter aortic valve replacement. Am J Cardiol 115:10 (2015), 1435–1442.
Baumgartner, H., Falk, V., Bax, J.J., et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease: the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 38:36 (2017), 2739–2791.
Nishimura, R.A., Otto, C.M., Bonow, R.O., et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 70:2 (2017), 252–289.
Martinez, C., Bernard, A., Dulgheru, R., et al. Pulmonary hypertension in aortic stenosis and mitral regurgitation: rest and exercise echocardiography significance. Prog Cardiovasc Dis 59:1 (2016), 59–70.
Ghoreishi, M., Evans, C.F., DeFilippi, C.R., et al. Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: implications for timing of surgery. J Thorac Cardiovasc Surg 142:6 (2011), 1439–1452.
Kainuma, S., Taniguchi, K., Toda, K., et al. Pulmonary hypertension predicts adverse cardiac events after restrictive mitral annuloplasty for severe functional mitral regurgitation. J Thorac Cardiovasc Surg 142:4 (2011), 783–792.
Miller, W.L., Mahoney, D.W., Enriquez-Sarano, M., Quantitative Doppler-echocardiographic imaging and clinical outcomes with left ventricular systolic dysfunction: independent effect of pulmonary hypertension. Circ Cardiovasc Imaging 7:2 (2014), 330–336.
Maréchaux, S., Neicu, D.V., Braun, S., et al. Functional mitral regurgitation: a link to pulmonary hypertension in heart failure with preserved ejection fraction. J Card Fail 17:10 (2011), 806–812.
Barbieri, A., Bursi, F., Grigioni, F., et al. Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study. Eur Heart J 32:6 (2011), 751–759.
Magne, J., Lancellotti, P., Piérard, L.A., Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. Circulation 122:1 (2010), 33–41.
Le Tourneau, T., Richardson, M., Juthier, F., et al. Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation. Heart 96 (2010), 1311–1317.
Mentias, A., Patel, K., Patel, H., et al. Effect of pulmonary vascular pressures on long-term outcome in patients with primary mitral regurgitation. J Am Coll Cardiol 67:25 (2016), 2952–2961.
Agricola, E., Stella, S., Gullace, M., et al. Impact of functional tricuspid regurgitation on heart failure and death in patients with functional mitral regurgitation and left ventricular dysfunction. Eur J Heart Fail 14:8 (2012), 902–908.
Kim, H.-K., Kim, Y.-J., Hwang, S.-J., et al. Hemodynamic and prognostic implications of net atrioventricular compliance in patients with mitral stenosis. J Am Soc Echocardiogr 21:5 (2008), 482–486.
Fawzy, M.E., Hassan, W., Stefadouros, M., et al. Prevalence and fate of severe pulmonary hypertension in 559 consecutive patients with severe rheumatic mitral stenosis undergoing mitral balloon valvotomy. J Heart Valve Dis 13:6 (2004), 942–947 [discussion: 947–8].
Maoqin, S., Guoxiang, H., Zhiyuan, S., et al. The clinical and hemodynamic results of mitral balloon valvuloplasty for patients with mitral stenosis complicated by severe pulmonary hypertension. Eur J Intern Med 16:6 (2005), 413–418.
Yang, H., Davidson, W.R. Jr., Chambers, C.E., et al. Preoperative pulmonary hypertension is associated with postoperative left ventricular dysfunction in chronic organic mitral regurgitation: an echocardiographic and hemodynamic study. J Am Soc Echocardiogr 19 (2006), 1051–1055.
Fawzy, M.E., Osman, A., Nambiar, V., et al. Immediate and long-term results of mitral balloon valvuloplasty in patients with severe pulmonary hypertension. J Heart Valve Dis 17:5 (2008), 485–491.
Yang, B., DeBenedictus, C., Watt, T., et al. The impact of concomitant pulmonary hypertension on early and late outcomes following surgery for mitral stenosis. J Thorac Cardiovasc Surg 152:2 (2016), 394–400.e1.
Parvathy, U.T., Rajan, R., Faybushevich, A.G., Reversal of abnormal cardiac parameters following mitral valve replacement for severe mitral stenosis in relation to pulmonary artery pressure: a retrospective study of noninvasive parameters - Early and late pattern. Interv Med Appl Sci 8:2 (2016), 49–59.
Nishimura, R.A., Otto, C.M., Bonow, R.O., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Thorac Cardiovasc Surg 148:1 (2014), e1–e132.
Bekeredjian, R., Grayburn, P.A., Valvular heart disease: aortic regurgitation. Circulation 112:1 (2005), 125–134.
Khandhar, S., Varadarajan, P., Turk, R., et al. Survival benefit of aortic valve replacement in patients with severe aortic regurgitation and pulmonary hypertension. Ann Thorac Surg 88:3 (2009), 752–756.
Naidoo, D.P., Mitha, A.S., Vythilingum, S., et al. Pulmonary hypertension in aortic regurgitation: early surgical outcome. Q J Med 80:291 (1991), 589–595.
Varadarajan, P., Patel, R., Turk, R., et al. Etiology impacts survival in patients with severe aortic regurgitation: results from a cohort of 756 patients. J Heart Valve Dis 22:1 (2013), 42–49.
Lewis, G.D., Murphy, R.M., Shah, R.V., et al. Pulmonary vascular response patterns during exercise in left ventricular systolic dysfunction predict exercise capacity and outcomes. Circ Heart Fail 4:3 (2011), 276–285.
Maréchaux, S., Hachicha, Z., Bellouin, A., et al. Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis. Eur Heart J 31:11 (2010), 1390–1397.
Lancellotti, P., Lebois, F., Simon, M., et al. Prognostic importance of quantitative exercise Doppler echocardiography in asymptomatic valvular aortic stenosis. Circulation 112:9 Suppl (2005), I377–I382.
Magne, J., Donal, E., Mahjoub, H., et al. Impact of exercise pulmonary hypertension on postoperative outcome in primary mitral regurgitation. Heart 101:5 (2015), 391–396.
Kusunose, K., Popović, Z.B., Motoki, H., et al. Prognostic significance of exercise-induced right ventricular dysfunction in asymptomatic degenerative mitral regurgitation. Circ Cardiovasc Imaging 6:2 (2013), 167–176.
Lancellotti, P., Magne, J., Dulgheru, R., et al. Clinical significance of exercise pulmonary hypertension in secondary mitral regurgitation. Am J Cardiol 115:10 (2015), 1454–1461.
Lancellotti, P., Gérard, P.L., Piérard, L.A., Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur Heart J 26:15 (2005), 1528–1532.
Piérard, L.A., Lancellotti, P., The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. N Engl J Med 351:16 (2004), 1627–1634.
Galli, E., Guirette, Y., Feneon, D., et al. Prevalence and prognostic value of right ventricular dysfunction in severe aortic stenosis. Eur Heart J Cardiovasc Imaging 16:5 (2015), 531–538.
Koifman, E., Didier, R., Patel, N., et al. Impact of right ventricular function on outcome of severe aortic stenosis patients undergoing transcatheter aortic valve replacement. Am Heart J 184 (2017), 141–147.
Vachiéry, J.-L., Adir, Y., Barberà, J.A., et al. Pulmonary hypertension due to left heart diseases. Turk Kardiyol Dern Ars 42:Suppl 1 (2014), 130–141 [in Turkish].
Testa, L., Latib, A., De Marco, F., et al. The failing right heart: implications and evolution in high-risk patients undergoing transcatheter aortic valve implantation. EuroIntervention 12:12 (2016), 1542–1549.
Ito, S., Pislaru, S.V., Soo, W.M., et al. Impact of right ventricular size and function on survival following transcatheter aortic valve replacement. Int J Cardiol 221 (2016), 269–274.
Lindman, B.R., Maniar, H.S., Jaber, W.A., et al. Effect of tricuspid regurgitation and the right heart on survival after transcatheter aortic valve replacement: insights from the placement of aortic transcatheter valves II inoperable cohort. Circ Cardiovasc Interv, 8(4), 2015 [pii:e002073].
Cavalcante, J.L., Rijal, S., Althouse, A.D., et al. Right ventricular function and prognosis in patients with low-flow, low-gradient severe aortic stenosis. J Am Soc Echocardiogr 29:4 (2016), 325–333.
Le Tourneau, T., de Groote, P., Millaire, A., et al. Effect of mitral valve surgery on exercise capacity, ventricular ejection fraction and neurohormonal activation in patients with severe mitral regurgitation. J Am Coll Cardiol 36:7 (2000), 2263–2269.
Le Tourneau, T., Deswarte, G., Lamblin, N., et al. Right ventricular systolic function in organic mitral regurgitation: impact of biventricular impairment. Circulation 127:15 (2013), 1597–1608.
Godino, C., Salerno, A., Cera, M., et al. Impact and evolution of right ventricular dysfunction after successful MitraClip implantation in patients with functional mitral regurgitation. Int J Cardiol Heart Vasc 11 (2016), 90–98.
Corciova, F.C., Corciova, C., Georgescu, C.A., et al. Echocardiographic predictors of adverse short-term outcomes after heart surgery in patients with mitral regurgitation and pulmonary hypertension. Heart Surg Forum 15:3 (2012), E127–E132.
Sun, X., Ellis, J., Kanda, L., et al. The role of right ventricular function in mitral valve surgery. Heart Surg Forum 16:3 (2013), E170–E176.
Kaneko, H., Neuss, M., Weissenborn, J., Butter, C., Prognostic Significance of Right Ventricular Dysfunction in Patients With Functional Mitral Regurgitation Undergoing MitraClip. Am J Cardiol 118:11 (2016 Dec 1), 1717–1722.
Neuss, M., Schau, T., Schoepp, M., et al. Patient selection criteria and midterm clinical outcome for MitraClip therapy in patients with severe mitral regurgitation and severe congestive heart failure. Eur J Heart Fail 15:7 (2013), 786–795.
De Bonis, M., Alfieri, O., MitraClip and right ventricular function: hopes and doubts. Eur Heart J Cardiovasc Imaging 15:1 (2014), 104–105.
Sagie, A., Freitas, N., Padial, L.R., et al. Doppler echocardiographic assessment of long-term progression of mitral stenosis in 103 patients: valve area and right heart disease. J Am Coll Cardiol 28:2 (1996), 472–479.
Mohan, J.C., Sengupta, P.P., Arora, R., Immediate and delayed effects of successful percutaneous transvenous mitral commissurotomy on global right ventricular function in patients with isolated mitral stenosis. Int J Cardiol 68:2 (1999), 217–223.
Burger, W., Illert, S., Teupe, C., et al. Right ventricular function in patients with rheumatic mitral valve stenosis. Effect of balloon mitral valvuloplasty. Z Kardiol 82:9 (1993), 545–551 [in German].
Harvey, R.M., Ferrer, I., Samet, P., et al. Mechanical and myocardial factors in rheumatic heart disease with mitral stenosis. Circulation 11:4 (1955), 531–551.
Mahfouz, R.A., Impact of pulmonary artery stiffness on right ventricular function and tricuspid regurgitation after successful percutaneous balloon mitral valvuloplasty: the importance of early intervention. Echocardiography 29:10 (2012), 1157–1163.
Kumar, V., Jose, V.J., Pati, P.K., et al. Assessment of right ventricular strain and strain rate in patients with severe mitral stenosis before and after balloon mitral valvuloplasty. Indian Heart J 66:2 (2014), 176–182.
Drighil, A., Bennis, A., Mathewson, J.W., et al. Immediate impact of successful percutaneous mitral valve commissurotomy on right ventricular function. Eur J Echocardiogr 9:4 (2008), 536–541.
Adavane, S., Santhosh, S., Karthikeyan, S., et al. Decrease in left atrium volume after successful balloon mitral valvuloplasty: an echocardiographic and hemodynamic study. Echocardiogr Mt Kisco N 28:2 (2011), 154–160.
Tigen, K., Pala, S., Sadic, B.O., et al. Effect of increased severity of mitral regurgitation and preprocedural right ventricular systolic dysfunction on biventricular and left atrial mechanical functions following percutaneous mitral balloon valvuloplasty. Echocardiogr Mt Kisco N 31:10 (2014), 1213–1220.
Dourvas, I.N., Parharidis, G.E., Efthimiadis, G.K., et al. Right ventricular diastolic function in patients with chronic aortic regurgitation. Am J Cardiol 93:1 (2004), 115–117.